ArticleAdvances in radiation oncology2026
Efficacy of Radiation Therapy in 106 Patients with Extramammary Paget Disease: A Retrospective Study.
Article in Advances in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Extramammary Paget disease (EMPD) is rare among Asians, and the clinical value of radiation therapy for EMPD remains controversial. This retrospective study evaluated the efficacy of radiation therapy for EMPD. Methods and Materials: From January 2012 to December 2021, 106 patients with pathologically confirmed EMPD with complete follow-up data were treated at Peking University First Hospital. The primary treatment was surgery combined with adjuvant radiation therapy, with radical radiation therapy for inoperable patients. The main surgical method for the primary lesion was Mohs micrographic surgery, with a few patients undergoing wide local excision. The recommended postoperative and radical radiation therapy doses were 50 to 60 Gy and 60 to 70 Gy, respectively. The primary endpoint was disease-specific survival rate; secondary endpoints included local recurrence-free survival, lymph node metastasis, and distant metastasis rates. Survival rates were determined using the Kaplan-Meier method and tested with the log-rank test. Univariate and multivariate prognostic analyses were performed using the Cox regression model. Results: The study population comprised 90 men and 16 women (male-to-female ratio, 5.6:1). The median age was 66 (range, 41-85) years. The median follow-up period was 66.5 (range, 5-139) months, with a median survival time of 132 months. The 1-, 3-, 5-, and 10-year disease-specific survival rates were 96%, 92%, 89%, and 89%, respectively; local recurrence-free survival rates were 99%, 99%, 95%, and 88%, respectively; lymph node metastasis rates were 3%, 5%, 9%, and 9%, respectively; and distant metastasis rates were 4%, 10%, 14%, and 17%, respectively. Univariate analysis revealed that the depth of invasion of the primary lesion was associated with local recurrence, with dermal involvement increasing the risk of local recurrence. Multivariate analysis revealed that the N and M stages were associated with disease prognosis. Conclusion: Radiation therapy is suitable for EMPD. Post-Mohs micrographic surgery radiation therapy provides excellent local control, and radical radiation therapy effectively controls tumors, including metastases.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.